LUCD Earnings Date & History
Lucid Diagnostics Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:36 PM ET
Lucid Diagnostics Inc
Health Care
- Next earnings date
- Tuesday, November 10, 2026
- Reporting session
- Before Open
- EPS estimate
- $-0.07
- Revenue estimate
- $2.0M
LUCD earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Wednesday, May 13, 2026 | Q1 2026 | $-0.08 | $-0.17 | -100.7% | $1.3M |
| Wednesday, March 25, 2026 | Q4 2025 | $-0.10 | $-0.10 | +2.0% | $1.5M |
| Wednesday, November 12, 2025 | Q3 2025 | $-0.11 | $-0.10 | +11.0% | $1.2M |
| Tuesday, August 12, 2025 | Q2 2025 | $-0.12 | $-0.08 | +35.2% | $1.2M |
What the market is watching in LUCD's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next LUCD earnings date?
- Lucid Diagnostics Inc is scheduled to report on Tuesday, November 10, 2026 (Before Open). Dates can change until the company confirms them.
- Does LUCD report before or after the market?
- The next report is scheduled before open.
- What EPS is expected for LUCD?
- Consensus EPS for the upcoming quarter is $-0.07, on revenue of $2.0M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
LUCD earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.